查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611260

2025-2030年美国血管通路装置市场规模、份额、按产品分類的趋势分析报告、按细分市场预测

U.S. Vascular Access Devices Market Size, Share & Trends Analysis Report By Product (Central Venous Catheters (CVC), Peripherally Inserted Central Catheter (PICCs)), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10个工作天内

价格

美国静脉通路装置市场趋势

预计 2024 年美国静脉通路装置市场规模将达到 14 亿美元，2025 年至 2030 年复合年增长率预计为 5.6%。

慢性病盛行率的不断上升以及对需要血管通路的医疗程序的需求不断增长推动了市场的成长。随着医疗保健提供者不断寻求有效的解决方案来输送药物、液体和营养物质，对创新静脉通路装置的需求预计将会增加。此外，抗菌涂层的开发以及将智慧技术整合到血管通路装置等技术进步有助于提高患者安全性和改善临床结果。

美国心血管疾病患者数量的增加预计将推动市场成长。根据美国心臟协会 2024 年 1 月发表的论文，CVD 在美国每天造成约 2,552 人死亡。 CVD 患者需要长期治疗，包括药物和液体治疗，通常透过中央静脉导管(CVC) 和周边置入中央静脉导管(PICC) 等静脉通路装置进行治疗。对心血管治疗的需求不断增长是市场的主要驱动力，因为这些设备在有效管理心血管疾病方面发挥关键作用。

美国静脉通路装置产业的成长也受到儿科患者越来越多地使用静脉通路装置的推动。例如，人口研究实验室在2024年1月预测，美国65岁以上人口数将从2022年的5,800万增加到2050年的8,200万，增加47%。此外，该年龄层人口占总人口的比例预计将从17%增加到23%。老年人更容易受到感染疾病，需要住院接受肠外营养 (PN) 治疗以维持体力、能量和水分。

此外，癌症患者数量的增加和对化疗的需求预计将推动市场成长。据美国国家癌症美国称，2024 年美国将诊断出约 2,001,140 例新癌症病例，预计将有 611,720 人死于该疾病。癌症治疗，尤其是化疗，在控制癌症方面发挥重要作用。根据健康成本研究所 2023 年 3 月发表的报导，美国每年有近 100 万人接受化疗。大多数这些治疗是透过静脉注射或註射进行的，通常需要患者去医生检查室或医院门诊诊所。

输液疗法在癌症治疗中的广泛使用凸显了静脉通路装置（例如周边置入中央静脉导管（PICC）和中央静脉导管（CVC））在化疗中的重要作用。这是因为这些设备对于确保接受治疗的癌症患者安全、有效且长期进入血液至关重要。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章美国静脉通路装置市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国静脉通路装置市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 管道分析

第四章美国静脉通路装置市场：依产品估算与趋势分析

  • 美国静脉通路装置市场：产品仪表板
  • 美国静脉通路装置市场：产品变化分析
  • 美国静脉通路装置市场（按产品、按收益）
  • 中央静脉导管（CVC）
    • 隧道CVC
    • 非隧道CVC
  • 周边静脉营养（PPN）
    • 高功能性
    • 标准

第五章竞争状况

  • 主要製造商的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 2024年主要企业市场占有率分析
  • 公司简介
    • BD
    • Teleflex
    • B Braun
    • Medical Components, Inc
    • Vygon SA
    • Medtronic/Mozarc Medical
    • Merit Medical/AngioDynamics
    • 其他的
Product Code: GVR-4-68040-493-3

U.S. Vascular Access Devices Market Trends:

The U.S. vascular access devices market size was estimated at USD 1.40 billion in 2024 and is expected to grow at a CAGR of 5.6% from 2025 to 2030. The market growth is driven by the increasing prevalence of chronic diseases and the growing need for medical procedures that require vascular access. As healthcare providers continue to seek efficient solutions for delivering medications, fluids, and nutrients, the demand for innovative vascular access devices is expected to rise. Additionally, advancements in technology, such as the development of antimicrobial coatings and the integration of smart technologies in vascular access devices, contribute to enhancing patient safety and improving clinical outcomes.

The rising CVD cases in the U.S. are expected to fuel the market growth. According to the American Heart Association article published in January 2024, in the U.S., CVD results in about 2,552 deaths each day. CVD patients require long-term treatments involving medications and fluids, often administered through vascular access devices like central venous catheters (CVCs) and peripherally inserted central catheters (PICCs). This growing demand for cardiovascular care is a key driver for the market, as these devices play a critical role in managing CVD effectively

The growth of the U.S. vascular access devices industry is also driven by rising use of vascular access devices among pediatric patients. For instance, in January 2024, the Population Reference Bureau had projected that the American population aged 65 and over would expand from 58 million in 2022 to 82 million by 2050, reflecting a 47% increase. Additionally, it was anticipated that the share of the total population belonging to this age bracket would grow from 17% to 23%. Older adults are easily susceptible to infectious diseases and need hospital treatment by administering parenteral nutrition (PN), which helps maintain strength, energy, and hydration.

In addition, increased cancer cases and chemotherapy demand is anticipated to drive the growth of the market. According to the National Cancer Institute, in 2024, it is projected that approximately 2,001,140 new cancer cases will be diagnosed in the United States, with an estimated 611,720 individuals expected to die from the disease. Cancer treatment, particularly chemotherapy, plays a crucial role in managing the condition. According to a Health Cost Institute article published in March 2023, nearly 1 million people in the U.S. undergo chemotherapy each year. Most of these treatments are administered via infusion or injection, often requiring patients to visit a physician's office or hospital outpatient department.

The widespread use of infusion therapies in cancer treatment underscores the critical role of vascular access devices, such as peripherally inserted central catheters (PICCs) and central venous catheters (CVCs), in delivering chemotherapy. This growing demand for oncology care is drives the North American vascular access devices market, as these devices are essential for ensuring safe, effective, and long-term access to the bloodstream for cancer patients undergoing treatment.

U.S. Vascular Access Devices Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. vascular access devices market report based on product:

  • Product Outlook (Revenue, USD Billion, 2018 - 2030)
  • Central Venous Catheters (CVC)
    • Tunneled CVC
    • Non-Tunneled CVC
  • Peripherally Inserted Central Catheter (PICCs)
    • Power Injected
    • Standard

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Vascular Access Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing prevalence of cardiovascular diseases
      • 3.2.1.2. Increasing need for vascular access devices in oncology
      • 3.2.1.3. Technological advancements in vascular access devices
      • 3.2.1.4. Rising use of vascular access devices among pediatric patients
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulations and product recalls
      • 3.2.2.2. Risks associated with catheter usage
  • 3.3. U.S. Vascular Access Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. U.S. Vascular Access Devices Market: Product Estimates & Trend Analysis

  • 4.1. Global U.S. Vascular Access Devices Market: Product Dashboard
  • 4.2. Global U.S. Vascular Access Devices Market: Product Movement Analysis
  • 4.3. Global U.S. Vascular Access Devices Market by Product, Revenue
  • 4.4. Central Venous Catheters (CVC)
    • 4.4.1. Central Venous Catheters (CVC) market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Tunneled CVC
      • 4.4.2.1. Tunneled CVC market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Non-Tunneled CVC
      • 4.4.3.1. Tunneled CV market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Peripheral Parenteral Nutrition (PPN)
    • 4.5.1. Peripheral parenteral nutrition (PPN) market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Power Injected
      • 4.5.2.1. Power Injected market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Standard
      • 4.5.3.1. Standard market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 5.2. Company/Competition Categorization
  • 5.3. Vendor Landscape
    • 5.3.1. List of key distributors and channel partners
    • 5.3.2. Key customers
    • 5.3.3. Key company market share analysis, 2024
  • 5.4. Company Profiles
    • 5.4.1. BD
      • 5.4.1.1. Company overview
      • 5.4.1.2. Financial performance
      • 5.4.1.3. Product benchmarking
      • 5.4.1.4. Strategic initiatives
    • 5.4.2. Teleflex
      • 5.4.2.1. Company overview
      • 5.4.2.2. Financial performance
      • 5.4.2.3. Product benchmarking
      • 5.4.2.4. Strategic initiatives
    • 5.4.3. B Braun
      • 5.4.3.1. Company overview
      • 5.4.3.2. Financial performance
      • 5.4.3.3. Product benchmarking
      • 5.4.3.4. Strategic initiatives
    • 5.4.4. Medical Components, Inc
      • 5.4.4.1. Company overview
      • 5.4.4.2. Financial performance
      • 5.4.4.3. Product benchmarking
      • 5.4.4.4. Strategic initiatives
    • 5.4.5. Vygon SA
      • 5.4.5.1. Company overview
      • 5.4.5.2. Financial performance
      • 5.4.5.3. Product benchmarking
      • 5.4.5.4. Strategic initiatives
    • 5.4.6. Medtronic/Mozarc Medical
      • 5.4.6.1. Company overview
      • 5.4.6.2. Financial performance
      • 5.4.6.3. Product benchmarking
      • 5.4.6.4. Strategic initiatives
    • 5.4.7. Merit Medical/AngioDynamics
      • 5.4.7.1. Company overview
      • 5.4.7.2. Financial performance
      • 5.4.7.3. Product benchmarking
      • 5.4.7.4. Strategic initiatives
    • 5.4.8. Others
      • 5.4.8.1. Company overview
      • 5.4.8.2. Financial performance
      • 5.4.8.3. Product benchmarking
      • 5.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. vascular access devices market, by product, 2018 - 2030 (USD Billion)
  • Table 3 Participant's overview
  • Table 4 Financial performance
  • Table 5 Key companies undergoing expansions
  • Table 6 Key companies undergoing acquisitions
  • Table 7 Key companies undergoing collaborations
  • Table 8 Key companies launching new products
  • Table 9 Key companies undergoing partnerships
  • Table 10 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 U.S. vascular access devices market: market outlook
  • Fig. 8 U.S. vascular access devices competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 U.S. vascular access devices market driver impact
  • Fig. 13 U.S. vascular access devices market restraint impact
  • Fig. 14 U.S. vascular access devices: Product movement analysis
  • Fig. 15 U.S. vascular access devices: Product outlook and key takeaways
  • Fig. 16 Central Venous Catheters (CVC) market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 17 Tunneled CVC market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 18 Non-Tunneled CVC market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 19 Peripherally Inserted Central Catheter (PICCs) market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Power Injected market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Standard market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Key company categorization
  • Fig. 23 Strategy mapping